to New Heights:
High Blood Pressure, Ryan Bendixen,
on Quest to
Conquer Mount Everest
Novartis Pharmaceuticals Corporation, makers of
Bendixen began his journey to the top of Mount Everest via the North Col on
April 4th. He is the first known person with high blood pressure
to attempt to summit. The climb is sponsored by Novartis Pharmaceuticals
Corp., makers of Diovan®,
the medication that Ryan takes to successfully manage his high blood
pressure. Ryan will be the first person ever to be tracking his blood
pressure throughout his climb. The effects of altitude on patients with high
blood pressure have not previously been studied. This will contribute to the understanding of altitude and blood pressure.
Bendixen’s Mt. Everest climb is being sponsored by Novartis Pharmaceuticals
Corporation, makers of Diovan®
should be discontinued as soon as pregnancy is detected because it may cause
death or injury to the unborn child. Diovan is contraindicated in patients who
are hypersensitive to the components of the product. The most common side
effects with Diovan in hypertensive patients were headache and dizziness.
Diovan is indicated for the treatment of hypertension. Diovan is not approved
to prevent or treat stroke, kidney damage, eye damage or heart attack.
information or full prescribing information for Diovan go to “Prescribing
Info/Quick Download” at